Procyon Pharmeceuticals


Public lists: Pharma Startups (4732)

Procyon Pharmecuticals, Inc. is an veterinary pharmecutical research and development company with a robust, theraputically diverse pipeline of products being developed to meet the needs of veterinarians and pet owners.

Procyon Pharmecuticals, Inc. is an veterinary pharmecutical research and development company with a robust, theraputically diverse pipeline of products being developed to meet the needs of veterinarians and pet owners.

Company (Alive / Active)

Phone:

Fax:

Madison, 53701
Wisconsin, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Procyon Pharmeceuticals $0M Nov 30, 2018
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Procyon Pharmeceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Trillium Therapeutics

Toronto, Ontario, Canada
IPO / Went publicTrillium Therapeutics is a research and development company developing therapies that restore balance to the immune system in conditions associated with aberrant and harmful immune responses, including autoimmune and inflammatory disorders, graft rejection, cancer and chronic viral diseases.Login to see details

Celera Genomics

Rockville, Maryland, United States
AcquiredCelera Genomics is one of three business segments of Applera Corporation. Celera Genomic's mission is to discover and develop meaningful new therapies that improve human health. We are applying our diverse genomics, bioinformatics, proteomics, medicinal chemistry and biology technology platforms to identify and validate drug targets, and to discover novel therapeutics. Celera Genomics currently has a portfolio of programs based primarily on protease inhibitors for three major therapeutic areas: ...Show allLogin to see details
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)